TEVA:NYE-Teva Pharma Industries Ltd ADR (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 17.95

Change

0.00 (0.00)%

Market Cap

N/A

Volume

3.61M

Analyst Target

USD 12.19
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

N/A

USD 87.57B
HLN Haleon plc

N/A

USD 45.67B
TAK Takeda Pharmaceutical Co Ltd A..

N/A

USD 45.20B
RDY Dr. Reddy’s Laboratories Ltd..

N/A

USD 13.38B
CTLT Catalent Inc

N/A

USD 10.94B
ELAN Elanco Animal Health

N/A

USD 6.34B
BHC Bausch Health Companies Inc

N/A

USD 3.00B
AMRX Amneal Pharmaceuticals, Inc. C..

N/A

USD 2.66B
CPHI China Pharma Holdings Inc

N/A

USD 4.27M
YCBD cbdMD Inc

N/A

USD 1.92M

ETFs Containing TEVA

ISRA VanEck Israel ETF 9.56 % 0.60 %

N/A

USD 0.08B
FLWR:SW 5.80 % 0.00 %

N/A

N/A
IDVO Amplify International Enh.. 2.93 % 0.00 %

N/A

USD 0.10B
ALFI 0.00 % 0.88 %

N/A

N/A
EIS iShares MSCI Israel ETF 0.00 % 0.59 %

N/A

N/A
GNRX 0.00 % 0.55 %

N/A

N/A
GWL 0.00 % 0.34 %

N/A

N/A
ISRPF iShares Public Limited Co.. 0.00 % 0.00 %

N/A

USD 2.22B
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
IS3T:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRCF iShares V Public Limited .. 0.00 % 0.00 %

N/A

N/A
ISRHF iShares V Public Limited .. 0.00 % 0.00 %

N/A

N/A
ISRUF iShares V Public Limited .. 0.00 % 0.00 %

N/A

N/A
ISRZF iShares II Public Limited.. 0.00 % 0.00 %

N/A

N/A
ISRIF 0.00 % 0.00 %

N/A

N/A
ISRVF 0.00 % 0.00 %

N/A

N/A
ISRWF 0.00 % 0.00 %

N/A

N/A
ISRNF 0.00 % 0.00 %

N/A

N/A
ISRRF 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -78.51% 7% C- 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -78.51% 7% C- 6% D-
Trailing 12 Months  
Capital Gain -72.37% 7% C- 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -72.37% 7% C- 7% C-
Trailing 5 Years  
Capital Gain -72.06% 21% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -72.06% 21% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain 9.54% 80% B- 66% D+
Dividend Return 9.54% 67% D+ 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 37.73% 53% F 26% F
Risk Adjusted Return 25.27% 60% D- 43% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector